Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cagrilintide for Sale > Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide
Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide buy - large image1
Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide buy - image1
Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide buy - image2
Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide buy - image3
Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide buy - image4
Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide buy - image5
Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide buy - image6

Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide

TDS 60 Inquiries

Unit Price: Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

HongKong

Brand:

Tranmoo

Packaging:

10mg*10vials

Price valid (until):

2026-05-27

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description



    WhatsAPP:+85247132718

    telegram:+85247132718

    Email:lxxxfffxxx@gmail.com

    Premium-Grade Research Compounds in Ready-to-Use Formats

    As a specialized peptide supplier, we provide a comprehensive selection of high-purity, lyophilized research peptides for scientific investigation. Our products are designed for in vitro studies, pre-clinical research, and pharmacological evaluation, catering to the needs of modern metabolic, neuroscience, and longevity research.Shop Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide-Detailed Image 1

    Shop Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide-Detailed Image 2 Shop Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide-Detailed Image 3

    About Product

    Appearance: Powder

    Purity: >99% (or refer to the Certificate of Analysis)

    Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

    Solubility: To be determined

    Shelf Life: >2 years if stored properly

    Drug Formulation: To be determined

    Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

    Peptide Storage Guidelines: General Tips

    When storing peptides, remember to:

    • Store peptide in a cold, dry, dark place
    • Avoid repeated freezing and thawing of peptide
    • Avoid overexposure to the air
    • Avoid light exposure
    • Avoid storing peptides in solution long term
    • Aliquot peptide according to experimental requirementsShop Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide-Detailed Image 4 Shop Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide-Detailed Image 5 Shop Cagrilintide+Semaglutide 5mg Combo | CAS 1415456-99-3 | Premium Stable Research Peptide-Detailed Image 6

    • Factory Footage

      Shop Retatrutide (CAS 2381089-83-2) Premium Research Peptide for Body Slimming and Lipolysis Studies-Detailed Image 6 Shop Retatrutide (CAS 2381089-83-2) Premium Research Peptide for Body Slimming and Lipolysis Studies-Detailed Image 7
      Shipping Methods

      Shop Retatrutide (CAS 2381089-83-2) Premium Research Peptide for Body Slimming and Lipolysis Studies-Detailed Image 8 Shop Retatrutide (CAS 2381089-83-2) Premium Research Peptide for Body Slimming and Lipolysis Studies-Detailed Image 9


    Why Source From Us?
    Guaranteed Purity & Consistency: All peptides are supplied as lyophilized powders with ≥95% purity (typically ≥99%), verified by HPLC and Mass Spec. Full Certificate of Analysis (CoA) provided.
    Convenient, Ready-to-Use Format: Pre-packaged in sterile, sealed vials (e.g., 5mg, 10mg per vial) in multi-vial packs, saving time and ensuring dosing accuracy.
    Bulk & Custom Synthesis Available: We offer competitive wholesale pricing for larger volumes and can accommodate custom peptide synthesis, modifications, or specific blending requests.
    Global Logistics & Discreet Shipping: We ensure reliable, temperature-conscious international delivery.


    Frequently Asked Questions (FAQs)
    Q1: What documentation is provided with the products?
    A1: Every order includes a batch-specific Certificate of Analysis (CoA) detailing HPLC purity, MS confirmation, endotoxin levels, and peptide content. MSDS is available upon request.
    Q2: How should I store and reconstitute the peptides?
    A2: Store all lyophilized vials at -20°C or below, desiccated and protected from light. For use, reconstitute with sterile bacteriostatic water or suitable solvent (specific recommendations available). Aliquot reconstituted solutions and store at ≤ -80°C to avoid degradation from repeated freeze-thaw cycles.
    Q3: What is the typical lead time and shipping method?
    A3: In-stock items ship within 3-5 business days. We use discreet, insulated packaging with cold gel packs for international shipments via reliable couriers. Tracking is provided.
    Q4: Can I request a custom blend or a peptide not listed?
    A4: Yes. Custom synthesis is our specialty. We can synthesize non-standard sequences, modify peptides (e.g., acetylation, pegylation), or prepare specific blends to your exact specifications. Contact us with your requirements for a quotation.


    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Certificates

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide

    Location:

    shenzhenshilonggangqulongchengjiedaohuanggekengshequjiazhaoyeshidaidasha902

    Average lead Time:

    15

    Year of Establishment:

    2024

    Shenzhen Chuanmu Technology Co., Ltd .

    Shenzhen Chuanmu Technology Co., Ltd. stands at the forefront of the biotechnology industry as a specialized leader dedicated to the research, development, and sales of high-purity, bioactive peptides. We integrate cutting-edge scientific innovation with an unwavering commitment to quality, serving a global clientele across pharmaceuticals, cosmetics, nutraceuticals, and research institutions.

    Driven by a mission to harness the power of peptides for health and advancement, our core strength lies in our advanced R&D capabilities. Our team of expert scientists utilizes state-of-the-art synthesis, purification, and analytical technologies to produce peptides of exceptional purity, consistency, and biological activity. We offer a comprehensive portfolio, including custom peptide synthesis, catalog peptides, generic APIs, and novel peptide-based formulations tailored to specific client requirements.

    Quality and reliability are the bedrock of our operations. Our processes adhere to the most stringent international standards, ensuring every product meets rigorous specifications for safety and efficacy. We are more than just a supplier; we are a strategic partner, providing robust technical support, confidential collaboration, and scalable solutions from preclinical stages to commercial production.

    Based in the dynamic innovation hub of Shenzhen, China, Shenzhen Chuanmu Technology is poised to accelerate your next breakthrough. We empower our partners to pioneer new treatments, enhance product performance, and push the boundaries of scientific discovery.

    Our Promise: Precision in Every Chain. Innovation for a Healthier Future.

  • Inquiry History
    60 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Hongkong, China

    Cagrilintide

    100 MG Apr 22, 2026
    United Kingdom

    Cagrilintide

    1 KG Apr 14, 2026
    Ireland

    Cagrilintide

    10 PCS Apr 14, 2026
    United States

    Cargrilintide

    10 MG Mar 19, 2026
    United Kingdom

    cagrilintide

    10 MG Feb 18, 2026
    China

    CagriSema cagrilintide 2.5mg+Samaglutide2.5mg

    10 MG Jan 26, 2026
    South Korea

    Cagrilintide

    500 MG Jan 21, 2026
    Pakistan

    cagrilintide

    1 KG Dec 26, 2025
    United States

    Cagrilintide

    20 MG Dec 19, 2025
    United Kingdom

    Cagrilintide

    100 MG Dec 10, 2025
    Canada

    All peptides

    1001 MT Nov 12, 2025
    United States

    Cagrilintide

    10 MG Oct 13, 2024
    United States

    Cagrilintide

    1 MG Jun 3, 2024
    United States

    Retatrutid3

    10 MT Aug 4, 2026
    United States

    Retatrutide

    20 MT Jul 25, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.